Imaging Study in Metastatic Clear Cell RCC.

Clinical trial NCT07671417 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07671417
Sponsor: RayzeBio, Inc.
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Metastatic Clear Cell Renal Cell Carcinoma

Start date: 2026-06-01
Primary completion: 2026-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.